C12N 9/2477
Hemicellulases not provided in a preceding group
Official title: {Hemicellulases not provided in a preceding group}
C12N9/2477 (Hemicellulases not provided in a preceding group) appears on 642 US grants and 831 published applications in this corpus.
Search patents in C12N- Granted patents
- 642
- Published applications
- 831
- Assignees
- 342
- Inventors
- 1,823
- Latest grant
- 25 Aug 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 1 | 0 |
| 1977 | 0 | 0 |
| 1978 | 0 | 0 |
| 1979 | 0 | 0 |
| 1980 | 0 | 0 |
| 1981 | 0 | 0 |
| 1982 | 0 | 0 |
| 1983 | 0 | 0 |
| 1984 | 3 | 0 |
| 1985 | 0 | 0 |
| 1986 | 1 | 0 |
| 1987 | 0 | 0 |
| 1988 | 2 | 0 |
| 1989 | 0 | 0 |
| 1990 | 4 | 0 |
| 1991 | 1 | 0 |
| 1992 | 1 | 0 |
| 1993 | 4 | 0 |
| 1994 | 4 | 0 |
| 1995 | 10 | 0 |
| 1996 | 8 | 0 |
| 1997 | 16 | 0 |
| 1998 | 14 | 0 |
| 1999 | 22 | 0 |
| 2000 | 13 | 0 |
| 2001 | 16 | 2 |
| 2002 | 9 | 13 |
| 2003 | 15 | 23 |
| 2004 | 7 | 12 |
| 2005 | 2 | 15 |
| 2006 | 7 | 15 |
| 2007 | 9 | 11 |
| 2008 | 10 | 19 |
| 2009 | 11 | 24 |
| 2010 | 14 | 22 |
| 2011 | 18 | 31 |
| 2012 | 19 | 48 |
| 2013 | 31 | 59 |
| 2014 | 40 | 60 |
| 2015 | 49 | 62 |
| 2016 | 35 | 62 |
| 2017 | 40 | 54 |
| 2018 | 37 | 41 |
| 2019 | 44 | 43 |
| 2020 | 25 | 35 |
| 2021 | 23 | 38 |
| 2022 | 18 | 26 |
| 2023 | 14 | 40 |
| 2024 | 13 | 29 |
| 2025 | 17 | 27 |
| 2026 | 15 | 20 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Recombinant endoxylanases and related compositions and methods of use25 Aug 2026US 12,716,082 B2Arizona Board of Regents on behalf of Arizona State University
- Xylanase variants and polynucleotides encoding same18 Aug 2026US 12,709,744 B2Novozymes A/S
- Human epidermal growth factor-TF fusion protein and use thereof14 Jul 2026US 12,679,875 B2Korea Institute of Ocean Science & Technology
- GH30 in wet milling23 Jun 2026US 12,662,692 B2Novozymes A/S
- Mannanase variants and polynucleotides encoding same16 Jun 2026US 12,655,368 B2Novozymes A/S
- Xylanase variants and polynucleotides encoding same8 Oct 2026US 2026/0308558 A1Novozymes A/S
- Polypeptides Having Xylanase Activity And Polynucleotides Encoding Same3 Sep 2026US 2026/0258386 A1Novozymes A/S
- Dough composition comprising non-starch polysaccharide degrading enzymes20 Aug 2026US 2026/0240175 A1Kerry Group Services International Limited
- Mannanase variants and polynucleotides encoding same20 Aug 2026US 2026/0242701 A1Novozymes A/S
- Methods for promoting plant health using free enzymes and microorganisms that overexpress enzymes30 Jul 2026US 2026/0217621 A1Spogen Biotech Inc.
Most cited
By later US patents
- Methods for producing modified glycoproteins158US 7,029,872 B2GlycoFi, Inc. · 2006
- Enzyme feed additive and animal feed107US 5,612,055 AFinnfeeds International Ltd. · 1997
- Ethanol production by recombinant hosts101US 5,424,202 AUniversity of Florida · 1995
- Method for isolating xylanase gene sequences from soil DNA, compositions useful in such method and compositions obtained thereby84US 5,849,491 ATerragen Diversity, Inc. · 1998
- Methods for producing modified glycoproteins84US 7,326,681 B2GlycoFi, Inc. · 2008